DKD welcomes research institutes, universities, hospitals, and mission-aligned organizations to collaborate on advancing our proprietary phospholipid platform. From joint research and co-invention to technology licensing, each form of collaboration is designed to translate platform science into safe, well-validated medical solutions for the community.
SCIENTIFIC COLLABORATION
DKD partners with universities, hospitals, and research institutes to advance research based on its proprietary phospholipid platform.
Rather than starting from fundamental phospholipid chemistry, collaborators gain access to an established platform that supports faster translation into clinical and biomedical applications.
Research CollaborationCo-developmentTechnology Translation
RESEARCH FUNDING
DKD co-funds high-potential research projects in humanitarian medicine, orphan drugs, and pediatric applications.
Support may include direct funding, access to testing facilities, or collaboration on international publications.
ESG & CSR FundsHumanitarian MedicineOrphan Drug Research
TECHNOLOGY TRANSFER & PATENT LICENSING
DKD offers exclusive licensing, patent utilization rights, and joint ventures to develop derivative products across new markets.
Partners receive comprehensive support across IP documentation, manufacturing processes, and quality control systems.
Patent LicensingJoint VenturesManufacturing Support